Intellia Therapeutics Statistics
Total Valuation
NTLA has a market cap or net worth of $1.18 billion. The enterprise value is $652.90 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, before market open.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
NTLA has 107.35 million shares outstanding. The number of shares has increased by 10.38% in one year.
Current Share Class | 107.35M |
Shares Outstanding | 107.35M |
Shares Change (YoY) | +10.38% |
Shares Change (QoQ) | +0.22% |
Owned by Insiders (%) | 1.51% |
Owned by Institutions (%) | 88.74% |
Float | 102.02M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 21.34 |
Forward PS | n/a |
PB Ratio | 1.62 |
P/TBV Ratio | 1.65 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 12.35 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.19, with a Debt / Equity ratio of 0.14.
Current Ratio | 5.19 |
Quick Ratio | 4.93 |
Debt / Equity | 0.14 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -56.95% and return on invested capital (ROIC) is -33.77%.
Return on Equity (ROE) | -56.95% |
Return on Assets (ROA) | -30.62% |
Return on Invested Capital (ROIC) | -33.77% |
Return on Capital Employed (ROCE) | -63.73% |
Revenue Per Employee | $131,159 |
Profits Per Employee | -$1.19M |
Employee Count | 403 |
Asset Turnover | 0.05 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.47% in the last 52 weeks. The beta is 2.31, so NTLA's price volatility has been higher than the market average.
Beta (5Y) | 2.31 |
52-Week Price Change | -49.47% |
50-Day Moving Average | 10.65 |
200-Day Moving Average | 10.77 |
Relative Strength Index (RSI) | 45.92 |
Average Volume (20 Days) | 4,995,288 |
Short Selling Information
The latest short interest is 29.71 million, so 27.68% of the outstanding shares have been sold short.
Short Interest | 29.71M |
Short Previous Month | 28.87M |
Short % of Shares Out | 27.68% |
Short % of Float | 29.12% |
Short Ratio (days to cover) | 6.18 |
Income Statement
In the last 12 months, NTLA had revenue of $52.86 million and -$480.19 million in losses. Loss per share was -$4.68.
Revenue | 52.86M |
Gross Profit | -387.25M |
Operating Income | -512.02M |
Pretax Income | -508.80M |
Net Income | -480.19M |
EBITDA | -501.87M |
EBIT | -512.02M |
Loss Per Share | -$4.68 |
Full Income Statement Balance Sheet
The company has $459.65 million in cash and $102.59 million in debt, giving a net cash position of $527.92 million or $4.92 per share.
Cash & Cash Equivalents | 459.65M |
Total Debt | 102.59M |
Net Cash | 527.92M |
Net Cash Per Share | $4.92 |
Equity (Book Value) | 715.26M |
Book Value Per Share | 6.79 |
Working Capital | 400.45M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$418.58 million and capital expenditures -$3.23 million, giving a free cash flow of -$421.82 million.
Operating Cash Flow | -418.58M |
Capital Expenditures | -3.23M |
Free Cash Flow | -421.82M |
FCF Per Share | -$3.93 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -968.69% |
Pretax Margin | -908.48% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NTLA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -10.38% |
Shareholder Yield | -10.38% |
Earnings Yield | -40.67% |
FCF Yield | -35.72% |
Dividend Details Analyst Forecast
The average price target for NTLA is $32.30, which is 193.64% higher than the current price. The consensus rating is "Buy".
Price Target | $32.30 |
Price Target Difference | 193.64% |
Analyst Consensus | Buy |
Analyst Count | 20 |
Revenue Growth Forecast (5Y) | 103.68% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
NTLA has an Altman Z-Score of -0.27 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.27 |
Piotroski F-Score | 3 |